Cardiol Therapeutics

Cardiol Therapeutics, a clinical-stage biotech in Oakville, is advancing CardiolRx—a cannabidiol therapy in Phase III trials for acute myocarditis and pericarditis. It also develops a subcutaneous injection for heart failure and uses nanotech, partnered with Meros.

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 18
HQ: Oakville

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
CRDL	Cardiol Therapeutics Cap: 0.1B	EQUITY	TOR	CAD	CA14161Y2006	Active	📈